The ARC is a collaboration between AMC, Reade and VUMC wherein rheumatologic research and education at these three organizations has been brought together in one organization.
The cooperation agreement was signed by the Boards of Directors of the three organizations on October 14, 2014.
Amsterdam Rheumatology and Immunology Center
We contribute to society with groundbreaking research
Although we focus on all rheumatic diseases, there are three syndromes that the ARC is most invested in: rheumatoid arthritis, Bechterew’s disease and systemic diseases, including vasculitis, systemic lupus eritematosis and scleroderma.
The ARC team
Within the Amsterdam Rheumatology & Immunology Center, more than 80 researchers work on the detection and treatment of rheumatic and immunological diseases.
Don't want to miss anything?
Sign up for our newsletter